Cardiovascular effects of marijuana and synthetic cannabinoids: The good, the bad, and the ugly

Keyphrases

• Cardiovascular Effects 100%
• Marijuana 100%
• Cannabinoid Receptor 1 (CB1R) 100%
• Synthetic Cannabinoids 100%
• Cannabinoid Receptor 2 80%
• Adverse Cardiovascular Events 40%
• Cardiovascular Pathology 40%
• Recreational Use 40%
• Central Nervous System 20%
• Dysregulation 20%
• Myocardial Infarction 20%
• Synthetic Analogues 20%
• Cardiomyopathy 20%
• Cardiovascular Disease 20%
• Cardiometabolic Disease 20%
• Arrhythmia 20%
• Cardiac Arrest 20%
• Endocannabinoids 20%
• Immune Cells 20%
• Cardiovascular System 20%
• Anti-inflammatory Effect 20%
• Endocannabinoid System 20%
• Cardiovascular Events 20%
• Endogenous Lipids 20%
• G Protein-coupled 20%
• Marijuana Legalization 20%
• Tetrahydrocannabinol 20%
• Cardiovascular Consequences 20%
• Lipid Mediators 20%
• Δ9-tetrahydrocannabinol (Δ9-THC) 20%
• Medicinal Purposes 20%

Biochemistry, Genetics and Molecular Biology

• Cannabinoid 100%
• Cardiovascular Effect 100%
• Tetrahydrocannabinol 66%
• Mediator 33%
• Lipid 33%
• Agonist 33%
• Cardiac Dysrhythmia 33%
• Immunocompetent Cell 33%
• G Protein 33%
• Antiinflammatory Activity 33%
• Cardiac Arrest 33%
• Cannabinoid Receptor 33%
• Endocannabinoid System 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Cannabis 100%
• Cannabinoid 100%
• Tetrahydrocannabinol 33%
• Disease 16%
• Heart Infarction 16%
• Cardiovascular Disease 16%
• Heart Arrhythmia 16%
• Heart Arrest 16%
• Endocannabinoid 16%
• Cardiomyopathy 16%
• Guanine Nucleotide Binding Protein 16%
• Antiinflammatory Activity 16%
• Endocannabinoid System 16%
• Cannabinoid 1 Receptor 16%
• Cannabinoid 2 Receptor 16%